294 related articles for article (PubMed ID: 31905247)
1. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
2. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
3. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
[TBL] [Abstract][Full Text] [Related]
5. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
6. A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.
Taylor SA; Yeap XY; Wang JJ; Gromer KD; Kriegermeier A; Green RM; Zhang ZJ
Physiol Rep; 2020 May; 8(10):e14446. PubMed ID: 32441483
[TBL] [Abstract][Full Text] [Related]
7. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
8. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
Feng H; Hu Y; Zhou S; Lu Y
J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
[TBL] [Abstract][Full Text] [Related]
13. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
14. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
[TBL] [Abstract][Full Text] [Related]
15. GGPPS deficiency aggravates CCl4-induced liver injury by inducing hepatocyte apoptosis.
Chen WB; Lai SS; Yu DC; Liu J; Jiang S; Zhao DD; Ding YT; Li CJ; Xue B
FEBS Lett; 2015 Apr; 589(10):1119-26. PubMed ID: 25819439
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 aggravates hepatic ischemia/reperfusion injury during obstructive cholestasis in bile duct ligated mice.
Nagai H; Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Nozawa S; Yoshitomi H; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
J Surg Res; 2010 Jul; 162(1):46-53. PubMed ID: 20552721
[TBL] [Abstract][Full Text] [Related]
17. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
[TBL] [Abstract][Full Text] [Related]
18. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
Allen K; Jaeschke H; Copple BL
Am J Pathol; 2011 Jan; 178(1):175-86. PubMed ID: 21224055
[TBL] [Abstract][Full Text] [Related]
19. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
[TBL] [Abstract][Full Text] [Related]
20. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
